tm logo
GIRZENVEQ
REGISTERED

on 19 Jul 2023

Last Applicant/ Owned by

PFIZER INC.

66 Hudson Boulevard EastNew York, New York 10001-2192

US

Serial Number

2093362 filed on 19th Mar 2021

Registration Number

TMA1190529 registered on 19th Jul 2023

Registration expiry Date

19th Jul 2033

Correspondent Address

SUITE 300079 WELLINGTON ST. W.BOX 270, TD CENTRETORONTO

ONTARIO

CA

M5K1N2

GIRZENVEQ

Trademark usage description

pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood, anxiety and cognitive disorders; pharmaceutical preparations for Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood, anxiety and cognitive disorders; pharmaceutical preparations for the treatment of neurodegenerative, nerve, neuromuscular and brain diseases and disorders, namely muscular dystrophy; Pharmaceutical preparations for the treatment of bone growth disorders; Pharmaceutical preparations for the treatment of the central nervous system, namely brain diseases and central nervous system movement disorders; Pharmaceutical preparations for the treatment of cardiovascular, gastrointestinal, blood, and diseases and disorders; Pharmaceutical preparations for the treatment of auto-immune diseases and disorders, namely rheumatoid arthritis, systemic lupus, alopecia areata, and systemic sclerosis; Pharmaceutical preparations for the treatment of hypertension, menopause symptoms, obesity, stroke, arthritis, and pain; Pharmaceutical preparations for the treatment of cancer; Anti-infectives, anti-inflammatories, anti-viral agents, human vaccines; Pharmaceutical preparations for use in discouraging smoking habits; Pharmaceutical preparations for the treatment of kidney and liver disease and disorders; Pharmaceutical preparations for the treatment of diseases and disorders of the endocrine system, namely growth and thyroid disorders; Pharmaceutical preparations for the treatment of inflammatory diseases, namely inflammatory bowel diseases, inflammatory joint diseases, inflammatory connective tissue diseases, inflammatory muscle diseases and disorders; Pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely cachexia, diabetes, hypoglycemia, muscular dystrophy, obesity, sickle cell disease, non-alcoholic steatohepatitis (NASH) and anemia; Pharmaceutical preparations for the treatment of skin and dermatological diseases and conditions, namely eczema, atopic dermatitis, psoriasis, bacterial skin infections, and viral skin infections.


Classification kind code

11

Mark Details


Serial Number

2093362

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 190
on 19th Jul 2023
Registration Pending
Submitted for opposition 135
on 30th Jun 2023
Amendment to Application
Submitted for opposition 42
on 19th Apr 2023
Advertised
Submitted for opposition 26
on 23rd Mar 2023
Approved
Submitted for opposition 27
on 23rd Mar 2023
Approval Notice Sent
Submitted for opposition 22
on 19th Mar 2023
Search Recorded
Submitted for opposition 287
on 29th Jun 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 19th Mar 2021
Filed
Submitted for opposition 1
on 19th Mar 2021
Created
Submitted for opposition 31
on 19th Mar 2021
Formalized